Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.

[1]  J. Goverman,et al.  Modeling the heterogeneity of multiple sclerosis in animals. , 2013, Trends in immunology.

[2]  B. Faubert,et al.  Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.

[3]  Linda V. Sinclair,et al.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.

[4]  J. T. Babcock,et al.  Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response* , 2013, The Journal of Biological Chemistry.

[5]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[6]  K. Guan,et al.  Amino acid signalling upstream of mTOR , 2013, Nature Reviews Molecular Cell Biology.

[7]  W. Paul,et al.  Cytokines of the γc family control CD4+ T cell differentiation and function , 2012, Nature Immunology.

[8]  G. V. D. Windt,et al.  Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.

[9]  A. Waickman,et al.  mTOR, metabolism, and the regulation of T‐cell differentiation and function , 2012, Immunological reviews.

[10]  E. Gottlieb,et al.  Glutaminolysis activates Rag-mTORC1 signaling. , 2012, Molecular cell.

[11]  Hongbo Chi,et al.  Regulation and function of mTOR signalling in T cell fate decisions , 2012, Nature Reviews Immunology.

[12]  B. Gorentla,et al.  Negative regulation of mTOR activation by diacylglycerol kinases. , 2011, Blood.

[13]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[14]  S. Hailfinger,et al.  Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. , 2010, Cold Spring Harbor perspectives in biology.

[15]  K. Frauwirth,et al.  Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.

[16]  D. Ayer,et al.  Coordination of glucose and glutamine utilization by an expanded Myc network , 2010, Transcription.

[17]  D. Sabatini,et al.  Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.

[18]  W. Paul,et al.  Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.

[19]  S. Miller,et al.  Experimental Autoimmune Encephalomyelitis in the Mouse , 2007 .

[20]  D. Ayer,et al.  Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity , 2009, Proceedings of the National Academy of Sciences.

[21]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[22]  Xin Lin,et al.  CARMA1‐mediated NF‐κB and JNK activation in lymphocytes , 2009, Immunological reviews.

[23]  Jeffrey P. MacKeigan,et al.  Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.

[24]  R. Pearson,et al.  Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation. , 2008, Blood.

[25]  James L. Park,et al.  A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. , 2008, American journal of physiology. Cell physiology.

[26]  Emanuela M. Iancu,et al.  The proteolytic activity of the paracaspase MALT1 is key in T cell activation , 2008, Nature Immunology.

[27]  J. Powell,et al.  A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus Anergy1 , 2007, The Journal of Immunology.

[28]  J. Mcgivan,et al.  The transport of glutamine into mammalian cells. , 2007, Frontiers in bioscience : a journal and virtual library.

[29]  O. Meyuhas,et al.  Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.

[30]  D. Sabatini,et al.  Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.

[31]  J. Blenis,et al.  Identification of S6 Kinase 1 as a Novel Mammalian Target of Rapamycin (mTOR)-phosphorylating Kinase* , 2005, Journal of Biological Chemistry.

[32]  J. Bertin,et al.  A requirement for CARMA1 in TCR-induced NF-κB activation , 2002, Nature Immunology.

[33]  J. Blenis,et al.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.

[34]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[35]  J. Bertin,et al.  A requirement for CARMA1 in TCR-induced NF-kappa B activation. , 2002, Nature immunology.

[36]  W. Souba,et al.  Glutamine metabolism in sepsis and infection. , 2001, The Journal of nutrition.

[37]  P. Newsholme,et al.  Glutamine Metabolism: Nutritional and Clinical Significance Why Is L-Glutamine Metabolism Important to Cells of the Immune System in Health, Postinjury, Surgery or Infection? , 2001 .

[38]  N. Sonenberg,et al.  Opposite Translational Control of GLUT1 and GLUT4 Glucose Transporter mRNAs in Response to Insulin , 1999, The Journal of Biological Chemistry.

[39]  Y. Kanai,et al.  Cloning and Functional Characterization of a System ASC-like Na+-dependent Neutral Amino Acid Transporter* , 1996, The Journal of Biological Chemistry.

[40]  Y. Mitsumoto,et al.  The Insulin-dependent Biosynthesis of GLUT1 and GLUT3 Glucose Transporters in L6 Muscle Cells Is Mediated by Distinct Pathways , 1995, The Journal of Biological Chemistry.

[41]  J. Watson,et al.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.

[42]  P. Lund,et al.  Inter-tissue nitrogen fluxes. , 1985, British medical bulletin.

[43]  S. G. Campbell,et al.  Immunity to intracellular bacteria. , 1982, Veterinary immunology and immunopathology.